All Comparisons/Aspirion vs DentalXChange

VNDRIQ — Vendor Comparison

Aspirion vs DentalXChange

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Aspirion63
DentalXChange43

Aspirion

Revenue Cycle

Verification pending

DentalXChange

Revenue Cycle

Last verified: September 15, 2026

VNDRIQ Scores

63

Overall

Privacy Score50
Governance Score71
Healthcare Readiness77
AI Risk Score55

43

Overall

Privacy Score17
Governance Score51
Healthcare Readiness32
AI Risk Score70

Approval Tier

Approved With Restrictions
Conditional / Verify BAA

BAA Status

Yes, as a Business Associate providing RCM services to covered entities, Aspirion enters into BAAs to manage PHI.
Verify Directly

PHI Exposure Risk

High
Critical

AI Training Risk

Medium
Low

HIPAA Risk Level

Low
Critical

Review Frequency

Quarterly

Annual

Recommended Use

Management of complex claims, clinical denials, payment variance, and underpayment recovery.

—

Restrictions

Use is restricted to authorized revenue cycle and financial personnel; requires a signed Business Associate Agreement (BAA) and adherence to HITRUST-certified workflows.

—

Executive Summary

Aspirion

Revenue Cycle

Aspirion is classified as Approved With Restrictions with a BAA status of Yes, as a Business Associate providing RCM services to covered entities, Aspirion enters into BAAs to manage PHI.. PHI exposure is rated High and AI training risk is Medium. Management of complex claims, clinical denials, payment variance, and underpayment recovery.

50

Privacy

71

Governance

77

Healthcare

55

AI Risk

DentalXChange

Revenue Cycle

DentalXChange is classified as Conditional / Verify BAA with a BAA status of Verify Directly. PHI exposure is rated Critical and AI training risk is Low.

17

Privacy

51

Governance

32

Healthcare

70

AI Risk

Recommended For

Aspirion

Management of complex claims, clinical denials, payment variance, and underpayment recovery.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

DentalXChange

Organizations able to execute BAA prior to deployment

IT teams with capacity to verify data handling agreements

Governance Considerations

Aspirion

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Use is restricted to authorized revenue cycle and financial personnel; requires a signed Business Associate Agreement (BAA) and adherence to HITRUST-certified workflows.

DentalXChange

BAA has not been confirmed. Execute BAA before processing PHI.

PHI exposure is elevated. Review data flow documentation.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.